Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease

Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...

Related Keywords

Denmark ,Germany ,Hannover ,Niedersachsen ,Claudia Ulbrich ,Frederik Taylor Pitter ,Sina Meyer ,Jacob Martin Wiborg ,Ambre James Brown ,Daniel Muusmann Bohsen ,David Heiberg Landsted ,Martin Holst Lange ,Novo Nordisk ,Cardior Pharmaceuticals ,Linkedin ,Facebook ,Development At Novo Nordisk ,Global Public Health Burden Of Heart Failure ,Trophic Communications ,Youtube ,Instagram ,European Heart ,Joseph Root ,Heart Journal ,Heart Failure ,Public Health Burden ,Markets ,